143 related articles for article (PubMed ID: 6223066)
1. Circulating T cell subsets in euthyroid Graves' disease.
Bagnasco M; Canonica GW; Ferrini S; Ciprandi G; Dirienzo W; Giordano G; Ferrini O
J Endocrinol Invest; 1983 Apr; 6(2):119-23. PubMed ID: 6223066
[TBL] [Abstract][Full Text] [Related]
2. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
[TBL] [Abstract][Full Text] [Related]
3. Activated (Ia+) T-cells and their subsets in Graves' disease and Hashimoto's thyroiditis using dual laser flow microfluorocytometric analysis.
Chan JY; Walfish PG
Mol Biol Med; 1986 Feb; 3(1):99-112. PubMed ID: 3083193
[TBL] [Abstract][Full Text] [Related]
4. T lymphocyte subsets in autoimmune thyroid diseases and subacute thyroiditis detected with monoclonal antibodies.
Iwatani Y; Amino N; Mori H; Asari S; Izumiguchi Y; Kumahara Y; Miyai K
J Clin Endocrinol Metab; 1983 Feb; 56(2):251-4. PubMed ID: 6218181
[TBL] [Abstract][Full Text] [Related]
5. Activated (Ia+) T-lymphocytes and their subsets in autoimmune thyroid diseases: analysis by dual laser flow microfluorocytometry.
Chan JY; Walfish PG
J Clin Endocrinol Metab; 1986 Feb; 62(2):403-9. PubMed ID: 3484483
[TBL] [Abstract][Full Text] [Related]
6. Decreased suppressor T-lymphocytes in autoimmune thyroid diseases detected by monoclonal antibodies.
Sridama V; Pacini F; DeGroot LJ
J Clin Endocrinol Metab; 1982 Feb; 54(2):316-9. PubMed ID: 6459338
[TBL] [Abstract][Full Text] [Related]
7. Circulating activated T cell subsets in autoimmune thyroid diseases: differences between untreated and treated patients.
Ohashi H; Okugawa T; Itoh M
Acta Endocrinol (Copenh); 1991 Nov; 125(5):502-9. PubMed ID: 1684685
[TBL] [Abstract][Full Text] [Related]
8. Blood mononuclear cells with suppressor activity in patients with thyroid disorders: increased levels of T gamma cells in subacute thyroiditis.
Wall JR; Chartier B
J Clin Lab Immunol; 1981 Sep; 6(2):115-9. PubMed ID: 6457155
[TBL] [Abstract][Full Text] [Related]
9. Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis.
Hidaka Y; Okumura M; Shimaoka Y; Takeoka K; Tada H; Amino N
Thyroid; 1998 Mar; 8(3):235-9. PubMed ID: 9545110
[TBL] [Abstract][Full Text] [Related]
10. Altered balance of immunoregulatory T lymphocyte subsets in autoimmune thyroid diseases.
Misaki T; Konishi J; Iida Y; Endo K; Torizuka K
Acta Endocrinol (Copenh); 1984 Feb; 105(2):200-4. PubMed ID: 6229968
[TBL] [Abstract][Full Text] [Related]
11. [Studies on the suppressor T cell function in patients with autoimmune thyroid diseases].
Matsui J
Nihon Naibunpi Gakkai Zasshi; 1984 Aug; 60(8):925-38. PubMed ID: 6096180
[TBL] [Abstract][Full Text] [Related]
12. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease.
Mori H; Amino N; Iwatani Y; Asari S; Izumiguchi Y; Kumahara Y; Miyai K
J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751
[TBL] [Abstract][Full Text] [Related]
13. Binding of immunoglobulin-G from patients with thyroid autoimmune disease to normal T lymphocytes.
Pacini F; Sridama V; Pressendo J; DeGroot LJ; Medof ME
Clin Endocrinol (Oxf); 1983 Jul; 19(1):29-37. PubMed ID: 6225570
[TBL] [Abstract][Full Text] [Related]
14. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.
Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M
J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751
[TBL] [Abstract][Full Text] [Related]
15. Production of IL-10 and IL-12 in CD40 and interleukin 4-activated mononuclear cells from patients with Graves' disease.
Itoh M; Uchimura K; Makino M; Kobayashi T; Hayashi R; Nagata M; Kakizawa H; Fujiwara K; Nagasaka A
Cytokine; 2000 Jun; 12(6):688-93. PubMed ID: 10843746
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell activity in patients with Graves' disease and Hashimoto's thyroiditis.
Wenzel BE; Chow A; Baur R; Schleusener H; Wall JR
Thyroid; 1998 Nov; 8(11):1019-22. PubMed ID: 9848716
[TBL] [Abstract][Full Text] [Related]
17. Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases.
Mariotti S; Caturegli P; Barbesino G; Marinò M; Del Prete GF; Chiovato L; Tonacchera M; De Carli M; Pinchera A
Clin Endocrinol (Oxf); 1992 Nov; 37(5):415-22. PubMed ID: 1486691
[TBL] [Abstract][Full Text] [Related]
18. Graves' disease associated with histologic Hashimoto's thyroiditis.
Falk SA; Birken EA; Ronquillo AH
Otolaryngol Head Neck Surg; 1985 Feb; 93(1):86-91. PubMed ID: 3920630
[TBL] [Abstract][Full Text] [Related]
19. Normal immunoregulation of in vitro antibody secretion in autoimmune thyroid disease.
MacLean DB; Miller KB; Brown R; Reichlin S
J Clin Endocrinol Metab; 1981 Oct; 53(4):801-5. PubMed ID: 6457056
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood T-lymphocyte subsets in autoimmune thyroid disease.
Covas MI; Esquerda A; García-Rico A; Mahy N
J Investig Allergol Clin Immunol; 1992; 2(3):131-5. PubMed ID: 1342892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
